FGF21 and metabolic dysfunction-associated steatotic liver disease: Furthermore, FGF21 can reduce liver fibrosis, inflammation, and damage by attenuating “multi-hits”, such as oxidative stress, ER stress, and chronic inflammation, in MASLD pathogenesis [191–193].